Nestlé Health Science, a Nestlé subsidiary dedicated to developing nutritional solutions for people with specific medical conditions, is investing CHF 67 million (USD 70 million) in a new Product Technology Centre in Bridgewater, New Jersey.
As part of Nestlé’s global R&D network, the facility will focus on developing innovative nutritional therapies that improve nutritional status and health outcomes for people in the US and other parts of the world.